Agios Pharmaceuticals (AGIO) Change in Inventory (2018 - 2026)

Agios Pharmaceuticals (AGIO) has disclosed Change in Inventory for 8 consecutive years, with $2.2 million as the latest value for Q1 2026.

  • For Q1 2026, Change in Inventory rose 8.95% year-over-year to $2.2 million; the TTM value through Mar 2026 reached $5.5 million, down 16.11%, while the annual FY2025 figure was $5.3 million, 37.89% down from the prior year.
  • Change in Inventory hit $2.2 million in Q1 2026 for Agios Pharmaceuticals, up from $886000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $4.3 million in Q2 2023 and bottomed at $867000.0 in Q2 2024.
  • Average Change in Inventory over 5 years is $2.1 million, with a median of $1.8 million recorded in 2023.
  • Year-over-year, Change in Inventory soared 172.83% in 2023 and then plummeted 79.82% in 2024.
  • Agios Pharmaceuticals' Change in Inventory stood at $3.3 million in 2022, then crashed by 45.66% to $1.8 million in 2023, then plummeted by 34.13% to $1.2 million in 2024, then dropped by 25.36% to $886000.0 in 2025, then soared by 144.58% to $2.2 million in 2026.
  • According to Business Quant data, Change in Inventory over the past three periods came in at $2.2 million, $886000.0, and $1.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.